The Traderszone Network

24 January, 2017 by The TZ Newswire Staff Comments Off on AUD and NZD orderboards

AUD and NZD orderboards

We get inflation data from Australia today (due at 0030GMT, , and ). Please take extra care over the release, extra volatility is expected. As is often the case on approach to (and over) important data releases limit orders are cancelled or reduced while stops losses are added in.

24 January, 2017 by The TZ Newswire Staff Comments Off on Commodities Corner: How a Republican border tax proposal could boost U.S. oil production and prices

Commodities Corner: How a Republican border tax proposal could boost U.S. oil production and prices

Proposed changes to the U.S. tax code could lift domestic crude prices by 25% over global prices, giving U.S.

read more

24 January, 2017 by The TZ Newswire Staff Comments Off on IBM Acquires Data Security Firm Agile 3 Solutions

IBM Acquires Data Security Firm Agile 3 Solutions

According to an IBM (NYSE: IBM) data security exec, the company bought its most recent acquisition — Agile 3 Solutions — because “we’ve seen security move from the back office to the front office and now to the board room.” Agile 3 Solutions develops software for high-level executives to manage the protection of sensitive data.

24 January, 2017 by The TZ Newswire Staff Comments Off on How Ethereum Smart Contracts Could Replace Mining Pool Operators

How Ethereum Smart Contracts Could Replace Mining Pool Operators

Ethereum smart contracts might one day be used to combat ‘mining centralization’, if a new project called SmartPool comes to fruition.

Source

24 January, 2017 by The TZ Newswire Staff Comments Off on Mark Zuckerberg says he’s not running for president

Mark Zuckerberg says he’s not running for president

“I’m focused on building our community at Facebook and working on the Chan Zuckerberg Initiative,” the Facebook CEO said.

24 January, 2017 by The TZ Newswire Staff Comments Off on Gilead Sciences Stock: What Could Go Wrong?

Gilead Sciences Stock: What Could Go Wrong?

In the wake of weakening hepatitis C drug revenue and key trial disappointments, Gilead Sciences (NASDAQ: GILD) shares have tumbled over the past year. Is now a good time to buy? Before you decide, it could help to understand what risks remain for the company and its investors.

Risk Arrow Pointing Down

Image source: Getty Images.

read more

24 January, 2017 by The TZ Newswire Staff Comments Off on You’ll never guess who just asked Trump to name China a currency manipulator

You’ll never guess who just asked Trump to name China a currency manipulator

“Mr. President: if you really want to put America first, label China a currency manipulator,” the senator told reporters.